Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control
about
Unspliced X-box-binding protein 1 (XBP1) protects endothelial cells from oxidative stress through interaction with histone deacetylase 3SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during agingEpigenetic modifications in double-strand break DNA damage signaling and repairThe many roles of histone deacetylases in development and physiology: implications for disease and therapyEpigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsHistone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fatDietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cellsHistone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesisNuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiologyInhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphomaHistone deacetylase 3 (HDAC3) participates in the transcriptional repression of the p16 (INK4a) gene in mammary gland of the female rat offspring exposed to an early-life high-fat dietVorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cellsSetd5 is essential for mammalian development and the co-transcriptional regulation of histone acetylation.Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesisRNAi screen in Drosophila larvae identifies histone deacetylase 3 as a positive regulator of the hsp70 heat shock gene expression during heat shock.Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancerHistone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathwayThe histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphomaHistone deacetylase 3 is required for iNKT cell developmentHistone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.HDAC3 controls gap 2/mitosis progression in adult neural stem/progenitor cells by regulating CDK1 levels.Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsEpigenetic changes in Alzheimer's disease: decrements in DNA methylationHdac3 is essential for the maintenance of chromatin structure and genome stability.Nuclear receptor corepressor complexes in cancer: mechanism, function and regulationHistone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.Histone deacetylases in skeletal development and bone mass maintenance.Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization.Interpreting clinical assays for histone deacetylase inhibitors.The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
P2860
Q24303544-6D850855-F011-45F4-B5EA-FBCCFAC9D2A2Q24595900-DA830217-5023-4F5F-A2DE-44BB7A2725BFQ24607287-FF5E679E-DBC2-403F-96A8-FE5FE7128376Q24628821-28B5312B-00E8-4AD2-8383-A73F39C510C6Q26741198-2956F0DF-4FCF-428E-A746-57A69985E1ECQ26853394-64438853-C2B3-4846-977E-5DF305C5D7F6Q27324052-EA031062-96F9-421C-8DB6-899BBE0BB00DQ28257534-68D0CBF4-71F4-4361-9A71-097B68CB0C44Q28509707-23F1CC5D-AB45-409B-82C3-A0EDF2F3D588Q28512844-D357C82A-CEA9-4B61-A3A1-36D7F21FA648Q28534761-D4D80C1A-FD12-4EAF-A880-5D3D1C3866FCQ28567581-FA5904D8-7270-4FF4-8FCB-799CEE434246Q28743758-0C52F611-F51F-430F-9F70-27D922B8FCF5Q32874823-A7FE62E6-669B-4C5F-ACE7-E33E3ABD88C2Q33390343-57B7DA2F-150E-45A6-A09E-FA5675AFA8B8Q33578947-1E4E6E77-D79E-4EE3-AF98-2764388DDF79Q33597363-DED85646-6976-4114-900A-2EB459BEAEC3Q33614697-4A82FB9F-E114-4E2D-90E8-692BE48EF978Q33648852-0EEDF6F5-CF94-41E2-9854-5639F3D41415Q33659166-6892BF4A-119B-4896-962D-6D97C4E0EE7BQ33705588-4E3E2459-D3F1-4C7F-BF80-9405D2C558CBQ33744417-C5CCEAB9-85EA-4D40-86E8-F22DD4D51BDCQ33784471-29E0D2A6-8B88-40BB-905F-FA7A74CE5E15Q33829390-3521C51C-F78B-4956-A105-4DDBB46843B6Q33853887-91692141-0409-4671-97B8-2F4BF660E661Q33918518-B56B108F-F1BE-41D3-92DB-A61DB19843ABQ33983255-CAD1D44A-932D-40C1-B8A5-72653DBB4F13Q33997928-475226E5-EADD-4B11-B0BC-86359C62B72BQ34218076-51C5AE73-7C9E-483B-BB72-619C99CD30BFQ34221822-0C5F0341-A2EE-4FB2-BC9E-8FE7D5256DB1Q34233161-927C3A82-4DC7-4E43-8524-EBCC49DC702BQ34417264-FE8DDED9-9297-46B1-9374-C461CA41BF7EQ34448240-B24E2510-8D65-4F24-91CD-551C5E0E64D7Q34541564-9C980263-E0D1-492A-806E-8C537BF81633Q34612849-FC64F5E0-D062-434B-AD3C-62D0D0709245Q34788395-6803F615-F8C5-45EA-ABEC-7A21912E7EAFQ34887304-D3CD742A-758D-439A-BD85-A993DAFC7381Q35003657-E9832089-B778-49C0-8D43-88FD61DDA23DQ35055598-4A301FF9-9A44-427C-B5E7-45A07A24E948Q35141937-ACFDA4A7-88C2-4887-8C18-7FABF8E050FC
P2860
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Deletion of histone deacetylas ...... ression and DNA damage control
@ast
Deletion of histone deacetylas ...... ression and DNA damage control
@en
type
label
Deletion of histone deacetylas ...... ression and DNA damage control
@ast
Deletion of histone deacetylas ...... ression and DNA damage control
@en
prefLabel
Deletion of histone deacetylas ...... ression and DNA damage control
@ast
Deletion of histone deacetylas ...... ression and DNA damage control
@en
P2093
P2860
P1433
P1476
Deletion of histone deacetylas ...... ression and DNA damage control
@en
P2093
Brenda J Chyla
David Cortez
Joseph M Amann
Sarah K Knutson
Scott W Hiebert
Srividya Bhaskara
Zu-Wen Sun
P2860
P356
10.1016/J.MOLCEL.2008.02.030
P577
2008-04-01T00:00:00Z